Viehbacher: Sanofi may extend Genzyme offer

Sanofi-Aventis CEO Chris Viehbacher told the French newspaper La Tribune that his company may extend its offer for Genzyme a third time. Despite reports that the two sides have reached an agreeable number, no fomal announcement has been made regarding a deal. Report

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.